Immunoproteomics: From biomarker discovery to diagnostic applications

Area of Science:

• Immunology
• Proteomics
• Clinical Diagnostics

Background:

• Circulating antibodies serve as molecular imprints of antigens linked to diseases like autoimmunity, cancer, and infections.
• Serum antibodies are valuable clinical markers, reflecting systemic health due to their stability and amplification by the humoral immune system.

Purpose of the Study:

• To review recent advances in immunoproteomics for biomarker discovery.
• To emphasize novel gel-free mass spectrometry (MS)-based approaches.
• To explore potential immunoproteomic applications in diagnostic medicine.

Main Methods:

• Review of current literature on immunoproteomics technologies.
• Focus on gel-free mass spectrometry (MS)-based methods for biomarker identification.
• Analysis of antibody stability and amplification in serum.

Main Results:

• Immunoproteomics, particularly gel-free MS approaches, shows significant promise for biomarker discovery.
• Antibodies are ideal candidates for diagnostic assays due to their stability and abundance post-antigen exposure.
• Advances facilitate the detection of low-abundance antigens through antibody profiling.

Conclusions:

• Immunoproteomics offers powerful tools for identifying novel disease biomarkers.
• Gel-free MS-based strategies are advancing biomarker discovery in serum antibody profiling.
• Future applications of immunoproteomics hold significant potential for early disease diagnosis and management.